GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Renovaro Inc (FRA:2Q5) » Definitions » Other Long Term Assets

Renovaro (FRA:2Q5) Other Long Term Assets : €0.02 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Renovaro Other Long Term Assets?

Renovaro's other long-term assets for the quarter that ended in Mar. 2024 was €0.02 Mil.

Renovaro's quarterly other long-term assets declined from Sep. 2023 (€0.02 Mil) to Dec. 2023 (€0.02 Mil) but then stayed the same from Dec. 2023 (€0.02 Mil) to Mar. 2024 (€0.02 Mil).

Renovaro's annual other long-term assets increased from Jun. 2021 (€0.02 Mil) to Jun. 2022 (€0.07 Mil) but then declined from Jun. 2022 (€0.07 Mil) to Jun. 2023 (€0.02 Mil).


Renovaro Other Long Term Assets Historical Data

The historical data trend for Renovaro's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renovaro Other Long Term Assets Chart

Renovaro Annual Data
Trend Mar13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.12 0.02 0.07 0.02

Renovaro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.02 0.02 0.02 0.02

Renovaro Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Renovaro (FRA:2Q5) Business Description

Traded in Other Exchanges
Address
2080 Century Park East, Suite 906, Los Angeles, CA, USA, 90067
Renovaro Biosciences Inc Formerly Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Renovaro (FRA:2Q5) Headlines

No Headlines